Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Comment: predictability of survival in the individual patient with lung cancer.

JAMA

Rubin P.
PMID: 5952099
JAMA. 1966 Mar 21;195(12):1036-7.

No abstract available.

Cite
Rubin P. Comment: predictability of survival in the individual patient with lung cancer. JAMA. 1966;195(12):1036-7
Rubin, P. (1966). Comment: predictability of survival in the individual patient with lung cancer. JAMA, 195(12), 1036-7.
Rubin, P. "Comment: predictability of survival in the individual patient with lung cancer." JAMA vol. 195,12 (1966): 1036-7.
Rubin P. Comment: predictability of survival in the individual patient with lung cancer. JAMA. 1966 Mar 21;195(12):1036-7. PMID: 5952099.
Copy Download .nbib Format: NLM
[Determination of the target area for radiotherapy. (I) A. Pathology of neoplasms in relation to radiotherapy, with special reference to lung neoplasms].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica

Shimozato Y.
PMID: 542369
Nihon Igaku Hoshasen Gakkai Zasshi. 1979 Nov;39(11):1193-5.

No abstract available.

Cite
Shimozato Y. [Determination of the target area for radiotherapy. (I) A. Pathology of neoplasms in relation to radiotherapy, with special reference to lung neoplasms]. Nihon Igaku Hoshasen Gakkai Zasshi. 1979;39(11):1193-5
Shimozato, Y. (1979). [Determination of the target area for radiotherapy. (I) A. Pathology of neoplasms in relation to radiotherapy, with special reference to lung neoplasms]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 39(11), 1193-5.
Shimozato, Y. "[Determination of the target area for radiotherapy. (I) A. Pathology of neoplasms in relation to radiotherapy, with special reference to lung neoplasms]." Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica vol. 39,11 (1979): 1193-5.
Shimozato Y. [Determination of the target area for radiotherapy. (I) A. Pathology of neoplasms in relation to radiotherapy, with special reference to lung neoplasms]. Nihon Igaku Hoshasen Gakkai Zasshi. 1979 Nov;39(11):1193-5. Japanese. PMID: 542369.
Copy Download .nbib Format: NLM
Newer concepts in the therapy of pulmonary malignancies.

The Journal of the Medical Society of New Jersey

Koven BJ.
PMID: 5247998
J Med Soc N J. 1968 Dec;65(12):652-4.

No abstract available.

Cite
Koven BJ. Newer concepts in the therapy of pulmonary malignancies. J Med Soc N J. 1968;65(12):652-4
Koven, B. J. (1968). Newer concepts in the therapy of pulmonary malignancies. The Journal of the Medical Society of New Jersey, 65(12), 652-4.
Koven, B J. "Newer concepts in the therapy of pulmonary malignancies." The Journal of the Medical Society of New Jersey vol. 65,12 (1968): 652-4.
Koven BJ. Newer concepts in the therapy of pulmonary malignancies. J Med Soc N J. 1968 Dec;65(12):652-4. PMID: 5247998.
Copy Download .nbib Format: NLM
[Small-cell carcinoma of the lung. Recent data].

La Presse medicale

Israel L.
PMID: 5637803
Presse Med. 1968 Jan 06;76(1):17-20.

No abstract available.

Cite
Israel L. Les cancers à petites cellules du poumon. Données récentes. [Small-cell carcinoma of the lung. Recent data]. Presse Med. 1968;76(1):17-20
Israel, L. (1968). Les cancers à petites cellules du poumon. Données récentes. [Small-cell carcinoma of the lung. Recent data]. La Presse medicale, 76(1), 17-20.
Israel, L. "Les cancers à petites cellules du poumon. Données récentes." [Small-cell carcinoma of the lung. Recent data]. La Presse medicale vol. 76,1 (1968): 17-20.
Israel L. Les cancers à petites cellules du poumon. Données récentes. [Small-cell carcinoma of the lung. Recent data]. Presse Med. 1968 Jan 06;76(1):17-20. French. PMID: 5637803.
Copy Download .nbib Format: NLM
Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.

Technology in cancer research & treatment

Cobben DC, de Boer HC, Tijssen RH, Rutten EG, van Vulpen M, Peerlings J, Troost EG, Hoffmann AL, van Lier AL.
PMID: 26589726
Technol Cancer Res Treat. 2016 Dec;15(6):NP47-NP60. doi: 10.1177/1533034615615249. Epub 2015 Nov 19.

Magnetic resonance imaging (MRI) provides excellent soft-tissue contrast and allows for specific scanning sequences to optimize differentiation between various tissue types and properties. Moreover, it offers the potential for real-time motion imaging. This makes magnetic resonance imaging an ideal...

Cite
Cobben DC, de Boer HC, Tijssen RH, et al. Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer. Technol Cancer Res Treat. 2015;15(6):NP47-NP60doi: 10.1177/1533034615615249.
Cobben, D. C., de Boer, H. C., Tijssen, R. H., Rutten, E. G., van Vulpen, M., Peerlings, J., Troost, E. G., Hoffmann, A. L., & van Lier, A. L. (2016). Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer. Technology in cancer research & treatment, 15(6), NP47-NP60. https://doi.org/10.1177/1533034615615249
Cobben, David C P, et al. "Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer." Technology in cancer research & treatment vol. 15,6 (2016): NP47-NP60. doi: https://doi.org/10.1177/1533034615615249
Cobben DC, de Boer HC, Tijssen RH, Rutten EG, van Vulpen M, Peerlings J, Troost EG, Hoffmann AL, van Lier AL. Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer. Technol Cancer Res Treat. 2016 Dec;15(6):NP47-NP60. doi: 10.1177/1533034615615249. Epub 2015 Nov 19. PMID: 26589726.
Copy Download .nbib Format: NLM
[Attitude of the physician to inoperable cancer of the lung].

La Revue du praticien

Decroix G.
PMID: 4131557
Rev Prat. 1973 Mar 01;23(13):1245-50.

No abstract available.

Cite
Decroix G. Attitude du médecin devant un cancer du poumon inopérable. [Attitude of the physician to inoperable cancer of the lung]. Rev Prat. 1973;23(13):1245-50
Decroix, G. (1973). Attitude du médecin devant un cancer du poumon inopérable. [Attitude of the physician to inoperable cancer of the lung]. La Revue du praticien, 23(13), 1245-50.
Decroix, G. "Attitude du médecin devant un cancer du poumon inopérable." [Attitude of the physician to inoperable cancer of the lung]. La Revue du praticien vol. 23,13 (1973): 1245-50.
Decroix G. Attitude du médecin devant un cancer du poumon inopérable. [Attitude of the physician to inoperable cancer of the lung]. Rev Prat. 1973 Mar 01;23(13):1245-50. French. PMID: 4131557.
Copy Download .nbib Format: NLM
Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Curran WJ.
PMID: 23945381
J Thorac Oncol. 2013 Sep;8(9):1116-7. doi: 10.1097/JTO.0b013e3182a61949.

No abstract available.

Cite
Curran WJ. Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?. J Thorac Oncol. 2013;8(9):1116-7doi: 10.1097/JTO.0b013e3182a61949.
Curran, W. J. (2013). Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 8(9), 1116-7. https://doi.org/10.1097/JTO.0b013e3182a61949
Curran, Walter J. "Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 8,9 (2013): 1116-7. doi: https://doi.org/10.1097/JTO.0b013e3182a61949
Curran WJ. Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?. J Thorac Oncol. 2013 Sep;8(9):1116-7. doi: 10.1097/JTO.0b013e3182a61949. PMID: 23945381.
Copy Download .nbib Format: NLM
Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer.

Anticancer research

Janssen S, VAN Oorschot B, Käsmann L, Schild SE, Rades D.
PMID: 28476824
Anticancer Res. 2017 May;37(5):2537-2540. doi: 10.21873/anticanres.11596.

AIM: To validate a score estimating the 6-month survival of lung cancer patients irradiated for locally advanced disease.PATIENTS AND METHODS: The validation cohort of this study included 125 patients. The score for each patient was calculated by adding the...

Cite
Janssen S, VAN Oorschot B, Käsmann L, et al. Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer Res. 2017;37(5):2537-2540doi: 10.21873/anticanres.11596.
Janssen, S., VAN Oorschot, B., Käsmann, L., Schild, S. E., & Rades, D. (2017). Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer research, 37(5), 2537-2540. https://doi.org/10.21873/anticanres.11596
Janssen, Stefan, et al. "Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer." Anticancer research vol. 37,5 (2017): 2537-2540. doi: https://doi.org/10.21873/anticanres.11596
Janssen S, VAN Oorschot B, Käsmann L, Schild SE, Rades D. Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer. Anticancer Res. 2017 May;37(5):2537-2540. doi: 10.21873/anticanres.11596. PMID: 28476824.
Copy Download .nbib Format: NLM
Radiotherapy for extensive stage small-cell lung cancer.

Lancet (London, England)

Golden EB, Shin SM, Schiff PB, Formenti SC.
PMID: 25890907
Lancet. 2015 Apr 04;385(9975):1290-1. doi: 10.1016/S0140-6736(15)60675-4.

No abstract available.

Cite
Golden EB, Shin SM, Schiff PB, et al. Radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015;385(9975):1290-1doi: 10.1016/S0140-6736(15)60675-4.
Golden, E. B., Shin, S. M., Schiff, P. B., & Formenti, S. C. (2015). Radiotherapy for extensive stage small-cell lung cancer. Lancet (London, England), 385(9975), 1290-1. https://doi.org/10.1016/S0140-6736(15)60675-4
Golden, Encouse B, et al. "Radiotherapy for extensive stage small-cell lung cancer." Lancet (London, England) vol. 385,9975 (2015): 1290-1. doi: https://doi.org/10.1016/S0140-6736(15)60675-4
Golden EB, Shin SM, Schiff PB, Formenti SC. Radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015 Apr 04;385(9975):1290-1. doi: 10.1016/S0140-6736(15)60675-4. PMID: 25890907.
Copy Download .nbib Format: NLM
Radiotherapy for extensive stage small-cell lung cancer.

Lancet (London, England)

Mansfield A, Mandrekar S.
PMID: 25890909
Lancet. 2015 Apr 04;385(9975):1291. doi: 10.1016/S0140-6736(15)60676-6.

No abstract available.

Cite
Mansfield A, Mandrekar S. Radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015;385(9975):1291doi: 10.1016/S0140-6736(15)60676-6.
Mansfield, A., & Mandrekar, S. (2015). Radiotherapy for extensive stage small-cell lung cancer. Lancet (London, England), 385(9975), 1291. https://doi.org/10.1016/S0140-6736(15)60676-6
Mansfield, Aaron, and Mandrekar, Sumithra. "Radiotherapy for extensive stage small-cell lung cancer." Lancet (London, England) vol. 385,9975 (2015): 1291. doi: https://doi.org/10.1016/S0140-6736(15)60676-6
Mansfield A, Mandrekar S. Radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015 Apr 04;385(9975):1291. doi: 10.1016/S0140-6736(15)60676-6. PMID: 25890909.
Copy Download .nbib Format: NLM
Radiotherapy quality assurance in clinical trials.

International journal of radiation oncology, biology, physics

Perez CA, Gardner P, Glasgow GP.
PMID: 6735787
Int J Radiat Oncol Biol Phys. 1984 Jun;10:119-25. doi: 10.1016/0360-3016(84)90460-7.

The goal of radiation therapy is to yield the greatest possible uncomplicated local and regional tumor control. An acceptable quality of life with few severe complications, anatomical defects or psychological disturbances should be an integral objective of excellent radiation...

Cite
Perez CA, Gardner P, Glasgow GP. Radiotherapy quality assurance in clinical trials. Int J Radiat Oncol Biol Phys. 1984;10:119-25doi: 10.1016/0360-3016(84)90460-7.
Perez, C. A., Gardner, P., & Glasgow, G. P. (1984). Radiotherapy quality assurance in clinical trials. International journal of radiation oncology, biology, physics, 10119-25. https://doi.org/10.1016/0360-3016(84)90460-7
Perez, C A, et al. "Radiotherapy quality assurance in clinical trials." International journal of radiation oncology, biology, physics vol. 10 (1984): 119-25. doi: https://doi.org/10.1016/0360-3016(84)90460-7
Perez CA, Gardner P, Glasgow GP. Radiotherapy quality assurance in clinical trials. Int J Radiat Oncol Biol Phys. 1984 Jun;10:119-25. doi: 10.1016/0360-3016(84)90460-7. PMID: 6735787.
Copy Download .nbib Format: NLM
A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer.

European review for medical and pharmacological sciences

Grzywa-Celińska A, Krusiński A, Szewczyk K, Grzycka-Kowalczyk L.
PMID: 32894546
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8394-8401. doi: 10.26355/eurrev_202008_22636.

OBJECTIVE: The TNM (Tumor, Node, Metastasis) classification of Union for International Cancer Control is a system describing the anatomical extent of the solid tumors that leads to staging and decision on the type of treatment. The latter TNM system...

Cite
Grzywa-Celińska A, Krusiński A, Szewczyk K, et al. A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer. Eur Rev Med Pharmacol Sci. 2020;24(16):8394-8401doi: 10.26355/eurrev_202008_22636.
Grzywa-Celińska, A., Krusiński, A., Szewczyk, K., & Grzycka-Kowalczyk, L. (2020). A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer. European review for medical and pharmacological sciences, 24(16), 8394-8401. https://doi.org/10.26355/eurrev_202008_22636
Grzywa-Celińska, A, et al. "A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer." European review for medical and pharmacological sciences vol. 24,16 (2020): 8394-8401. doi: https://doi.org/10.26355/eurrev_202008_22636
Grzywa-Celińska A, Krusiński A, Szewczyk K, Grzycka-Kowalczyk L. A single-institution retrospective analysis of the differences between 7th and 8th edition of the UICC TNM staging system in patients with advanced lung cancer. Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8394-8401. doi: 10.26355/eurrev_202008_22636. PMID: 32894546.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries